Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial by Silk, SE, Kalinga, WF, Salkeld, J, Mtaka, IM, Ahmed, S, Milando, F, Diouf, A, Bundi, CK, Balige, N, Hassan, O, Mkindi, CG, Rwezaula, S, Athumani, T, Mswata, S, Lilolime, NS, Simon, B, Msami, H, Mohamed, M, David, DM, Mohammed, L, Nyaulingo, G, Mwalimu, B, Juma, O, Mwamlima, TG, Sasamalo, IA, Mkumbange, RP, Kamage, JJ, Barrett, JR, King, LDW, Hou, MM, Pulido, D, Carnrot, C, Lawrie, AM, Cowan, RE, Nugent, FL, Roberts, R, Cho, J-S, Long, CA, Nielsen, CM, Miura, K, Draper, SJ, Olotu, AI, Minassian, AM

“…We recruited healthy adults (aged 18–45 years) and children (aged 5–17 months) to receive the RH5.1/Matrix-M vaccine candidate in the following three-dose regimens: 10 μg RH5.1 at 0, 1, and 2 months (Adults 10M), and the higher dose of 50 μg RH5.1 at 0 and 1 month and 10 μg RH5.1 at 6 months (delayed-fractional third dose regimen; Adults DFx). …”

Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 by Ward, Joseph L., Azzopardi, Peter S., Francis, Kate L., Santelli, John S., Skirbekk, Vegard, Sawyer, Susan M., Kassebaum, Nicholas J., Mokdad, Ali H., Hay, Simon I., Abd-Allah, Foad, Abdoli, Amir, Mohammad Abdollahi, Abedi, Aidin, Abolhassani, Hassan, Abreu, Lucas Guimaraes, Abrigo, Michael R. M., Abu-Gharbieh, Eman, Abushouk, Abdelrahman I., Adebayo, Oladimeji M., Adekanmbi, Victor, Adham, Davoud, Advani, Shailesh M., Afshari, Khashayar, Agrawal, Anurag, Ahmad, Tauseef, Ahmadi, Keivan, Ahmed, Anwar E., Aji, Budi, Akombi-Inyang, Blessing, Alahdab, Fares, Al-Aly, Ziyad, Alam, Khurshid, Alanezi, Fahad Mashhour, Alanzi, Turki M., Alcalde-Rabanal, Jacqueline Elizabeth, Alemu, Biresaw Wassihun, Al-Hajj, Samar, Alhassan, Robert Kaba, Ali, Saqib, Alicandro, Gianfranco, Alijanzadeh, Mehran, Aljunid, Syed Mohamed, Almasi-Hashiani, Amir, Almasri, Nihad A., Al-Mekhlafi, Hesham M., Alonso, Jordi, Al-Raddadi, Rajaa M., Altirkawi, Khalid A., Alvis-Guzman, Nelson, Amare, Azmeraw T., Amini, Saeed, Aminorroaya, Arya, Amit, Arianna Maever L., Amugsi, Dickson A., Ancuceanu, Robert, Anderlini, Deanna, Andrei, Catalina Liliana, Androudi, Sofia, Ansari, Fereshteh, Ansari, Iman, Antonio, Carl Abelardo T., Anvari, Davood, Anwer, Razique, Appiah, Seth Christopher Yaw, Arabloo, Jalal, Arab-Zozani, Morteza, Ärnlöv, Johan, Asaad, Malke, Asadi-Aliabadi, Mehran, Asadi-Pooya, Ali A., Atout, Maha Moh'd Wahbi, Ausloos, Marcel, Avenyo, Elvis Korku, Avila-Burgos, Leticia, Quintanilla, Beatriz Paulina Ayala, Ayano, Getinet, Aynalem, Yared Asmare, Azari, Samad, Azene, Zelalem Nigussie, Bakhshaei, Mohammad Hossein, Bakkannavar, Shankar M., Banach, Maciej, Banik, Palash Chandra, Barboza, Miguel A., Barker-Collo, Suzanne Lyn, Bärnighausen, Till Winfried, Basu, Sanjay, Baune, Bernhard T., Bayati, Mohsen, Bedi, Neeraj, Beghi, Ettore, Bekuma, Tariku Tesfaye, Bell, Arielle Wilder, Bell, Michelle L., Benjet, Corina, Bensenor, Isabela M., Berhe, Abadi Kidanemariam, Berhe, Kidanemaryam, Berman, Adam E., Bhagavathula, Akshaya Srikanth, Car, Lorainne Tudor

“…We analyse variation in outcomes by region, age group, and sex, and compare annual rate of change in mortality in young people aged 10–24 years with that in children aged 0–9 years from 1990 to 2019. We then analyse the association between mortality in people aged 10–24 years and socioeconomic development using the GBD Socio-demographic Index (SDI), a composite measure based on average national educational attainment in people older than 15 years, total fertility rate in people younger than 25 years, and income per capita. …”
Get full text

MAS.962 Autism Theory and Technology, Spring 2007 by Breazeal, Cynthia, el Kaliouby, Rana, Picard, Rosalind W., Turkle, Sherry

“…Students will not only develop new technologies, but also understand, help, and learn from people with autism, a fast-growing group that the CDC identified in the year 2005 as involving an estimated 1 in 150 school-age children ages 6-21. Students will gain an understanding of the basic challenges faced by people diagnosed with autism spectrum disorders, together with their families and caregivers, and an understanding of the fundamental theories that inform therapies and technologies for improving the autistic experience. …”
Get full text

Cortical tracking of speech-in-noise develops from childhood to adulthood by Vander Ghinst, Marc, Bourguignon, Mathieu, Niesen, Maxime, Wens, Vincent, Hassid, Sergio, Choufani, Georges, Jousmäki, Veikko, Hari, Riitta, Goldman, Serge, De Tiège, Xavier

“…We used magnetoencephalography (MEG) to investigate the frequency-specific cortical tracking of different elements of a cocktail party auditory scene in 20 children (age range, 6-9 years; 8 females) and 20 adults (age range, 21-40 years; 10 females). …”
Get full text